Cargando…

ITIH4 acts as a protease inhibitor by a novel inhibitory mechanism

Inter-α-inhibitor heavy chain 4 (ITIH4) is a poorly characterized plasma protein that is proteolytically processed in multiple pathological conditions. However, no biological function of ITIH4 has been identified. Here, we show that ITIH4 is cleaved by several human proteases within a protease-susce...

Descripción completa

Detalles Bibliográficos
Autores principales: Pihl, Rasmus, Jensen, Rasmus K., Poulsen, Emil C., Jensen, Lisbeth, Hansen, Annette G., Thøgersen, Ida B., Dobó, József, Gál, Péter, Andersen, Gregers R., Enghild, Jan J., Thiel, Steffen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7793589/
https://www.ncbi.nlm.nih.gov/pubmed/33523981
http://dx.doi.org/10.1126/sciadv.aba7381
_version_ 1783634022728990720
author Pihl, Rasmus
Jensen, Rasmus K.
Poulsen, Emil C.
Jensen, Lisbeth
Hansen, Annette G.
Thøgersen, Ida B.
Dobó, József
Gál, Péter
Andersen, Gregers R.
Enghild, Jan J.
Thiel, Steffen
author_facet Pihl, Rasmus
Jensen, Rasmus K.
Poulsen, Emil C.
Jensen, Lisbeth
Hansen, Annette G.
Thøgersen, Ida B.
Dobó, József
Gál, Péter
Andersen, Gregers R.
Enghild, Jan J.
Thiel, Steffen
author_sort Pihl, Rasmus
collection PubMed
description Inter-α-inhibitor heavy chain 4 (ITIH4) is a poorly characterized plasma protein that is proteolytically processed in multiple pathological conditions. However, no biological function of ITIH4 has been identified. Here, we show that ITIH4 is cleaved by several human proteases within a protease-susceptible region, enabling ITIH4 to function as a protease inhibitor. This is exemplified by its inhibition of mannan-binding lectin–associated serine protease-1 (MASP-1), MASP-2, and plasma kallikrein, which are key proteases for intravascular host defense. Mechanistically, ITIH4 acts as bait that, upon cleavage, forms a noncovalent, inhibitory complex with the executing protease that depends on the ITIH4 von Willebrand factor A domain. ITIH4 inhibits the MASPs by sterically preventing larger protein substrates from accessing their active sites, which remain accessible and fully functional toward small substrates. Thus, we demonstrate that ITIH4 functions as a protease inhibitor by a previously undescribed inhibitory mechanism.
format Online
Article
Text
id pubmed-7793589
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher American Association for the Advancement of Science
record_format MEDLINE/PubMed
spelling pubmed-77935892021-01-15 ITIH4 acts as a protease inhibitor by a novel inhibitory mechanism Pihl, Rasmus Jensen, Rasmus K. Poulsen, Emil C. Jensen, Lisbeth Hansen, Annette G. Thøgersen, Ida B. Dobó, József Gál, Péter Andersen, Gregers R. Enghild, Jan J. Thiel, Steffen Sci Adv Research Articles Inter-α-inhibitor heavy chain 4 (ITIH4) is a poorly characterized plasma protein that is proteolytically processed in multiple pathological conditions. However, no biological function of ITIH4 has been identified. Here, we show that ITIH4 is cleaved by several human proteases within a protease-susceptible region, enabling ITIH4 to function as a protease inhibitor. This is exemplified by its inhibition of mannan-binding lectin–associated serine protease-1 (MASP-1), MASP-2, and plasma kallikrein, which are key proteases for intravascular host defense. Mechanistically, ITIH4 acts as bait that, upon cleavage, forms a noncovalent, inhibitory complex with the executing protease that depends on the ITIH4 von Willebrand factor A domain. ITIH4 inhibits the MASPs by sterically preventing larger protein substrates from accessing their active sites, which remain accessible and fully functional toward small substrates. Thus, we demonstrate that ITIH4 functions as a protease inhibitor by a previously undescribed inhibitory mechanism. American Association for the Advancement of Science 2021-01-08 /pmc/articles/PMC7793589/ /pubmed/33523981 http://dx.doi.org/10.1126/sciadv.aba7381 Text en Copyright © 2021 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC). https://creativecommons.org/licenses/by-nc/4.0/ https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial license (https://creativecommons.org/licenses/by-nc/4.0/) , which permits use, distribution, and reproduction in any medium, so long as the resultant use is not for commercial advantage and provided the original work is properly cited.
spellingShingle Research Articles
Pihl, Rasmus
Jensen, Rasmus K.
Poulsen, Emil C.
Jensen, Lisbeth
Hansen, Annette G.
Thøgersen, Ida B.
Dobó, József
Gál, Péter
Andersen, Gregers R.
Enghild, Jan J.
Thiel, Steffen
ITIH4 acts as a protease inhibitor by a novel inhibitory mechanism
title ITIH4 acts as a protease inhibitor by a novel inhibitory mechanism
title_full ITIH4 acts as a protease inhibitor by a novel inhibitory mechanism
title_fullStr ITIH4 acts as a protease inhibitor by a novel inhibitory mechanism
title_full_unstemmed ITIH4 acts as a protease inhibitor by a novel inhibitory mechanism
title_short ITIH4 acts as a protease inhibitor by a novel inhibitory mechanism
title_sort itih4 acts as a protease inhibitor by a novel inhibitory mechanism
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7793589/
https://www.ncbi.nlm.nih.gov/pubmed/33523981
http://dx.doi.org/10.1126/sciadv.aba7381
work_keys_str_mv AT pihlrasmus itih4actsasaproteaseinhibitorbyanovelinhibitorymechanism
AT jensenrasmusk itih4actsasaproteaseinhibitorbyanovelinhibitorymechanism
AT poulsenemilc itih4actsasaproteaseinhibitorbyanovelinhibitorymechanism
AT jensenlisbeth itih4actsasaproteaseinhibitorbyanovelinhibitorymechanism
AT hansenannetteg itih4actsasaproteaseinhibitorbyanovelinhibitorymechanism
AT thøgersenidab itih4actsasaproteaseinhibitorbyanovelinhibitorymechanism
AT dobojozsef itih4actsasaproteaseinhibitorbyanovelinhibitorymechanism
AT galpeter itih4actsasaproteaseinhibitorbyanovelinhibitorymechanism
AT andersengregersr itih4actsasaproteaseinhibitorbyanovelinhibitorymechanism
AT enghildjanj itih4actsasaproteaseinhibitorbyanovelinhibitorymechanism
AT thielsteffen itih4actsasaproteaseinhibitorbyanovelinhibitorymechanism